VERIX
AtlasCompareReconstitution & dosing
Growth Hormone Axis
Performance
Longevity
Limited
Research chemical

CJC-1295 + Ipamorelin Stack

Also known as CJC/IPA · GH peptide stack

New

Reconstitution & dosing guide

10 mg vial — research phases, recon steps, and a live unit calculator.

Open guide

Available sizes & price

Catalog only

10mg x 10 vials

CJC 1295 (without DAC) 5mg+IPA 5mg · Not in current stock

$50 / vial

Add

Prices per vial · Research use only · Not medical advice.

The default growth-hormone peptide stack in biohacking: GHRH analog + selective GHRP for physiologic pulses.

How to picture it

Two different keys to the same pituitary GH door. CJC (GHRH-analog path) asks via one receptor family; ipamorelin asks via the ghrelin receptor with a relatively selective profile. Together they are studied for stronger, well-shaped GH pulses than either alone — dual-channel "please release GH" signaling without defaulting to the loudest possible secretagogue.

Research focus & benefits

  • Dual secretagogue GH-pulse research
  • Synergistic GHRH + GHRP pathway interest
  • Recovery and body-composition stack studies

Benefits describe research interest and pathway rationale — not guaranteed outcomes or medical advice. Research use only.

Overview

Rather than a single molecule, CJC-1295 (no DAC) combined with Ipamorelin is the most referenced GH-axis peptide stack. The pairing aims to amplify pituitary GH pulses with fewer side effects than older GHRPs or flat DAC-driven elevation. Often night-dosed for sleep and recovery goals.

Mechanism

Dual stimulation: GHRH receptor + ghrelin receptor cooperation produces larger GH pulses than either alone.

Research uses

  • GH optimization clinics
  • Body composition programs
  • Recovery protocols

Research dosing notes

Often combined in the same syringe in community practice (compatibility claims vary). Empty stomach, pre-bed is common. Medical supervision preferred.

Open full reconstitution & dosing guide →

Half-life / kinetics

Component-dependent; effects timed to pulses

Common research routes

Subcutaneous injection

Reported considerations

  • Water retention
  • Tingling
  • Hunger (milder than GHRP-6)
  • IGF-1 elevation

Contraindications / cautions

  • Active cancer
  • Pregnancy
  • Uncontrolled diabetes

Common research stacks

  • BPC-157
  • TB-500
  • Tesamorelin (advanced)

Legal / access note

Neither component is approved as an anti-aging stack; research/clinic gray zones apply.